Prevalence of UBA1 mutations in MDS/CMML patients with systemic inflammatory and auto-immune disease-Reference-Cited by-同舟云学术

Prevalence of UBA1 mutations in MDS/CMML patients with systemic inflammatory and auto-immune disease

Published:2021-08-03 Issue:9 Volume:35 Page:2731-2733
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Zhao Lin-Pierre^ORCID,Schell Berenice^ORCID,Sébert Marie,Kim Rathana^ORCID,Lemaire Pierre,Boy Maxime^ORCID,Mathis Stephanie,Larcher Lise,Chauvel Clémentine,Dhouaieb Mohamed Bedis,Bisio Valéria,Preudhomme Claude,Marceau-Renaut Alice,Itzykson Raphaël,Mekinian Arsène,Fain Olivier,Toubert Antoine^ORCID,Fenaux Pierre,Dulphy Nicolas^ORCID,Clappier Emmanuelle,Adès Lionel^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-021-01353-8.pdf

Reference10 articles.

1. Winter S, Shoaie S, Kordasti S, Platzbecker U. Integrating the « Immunome » in the stratification of myelodysplastic syndromes and future clinical trial design. J Clin Oncol. 2020;38:1723–35.

2. Zhao L-P, Boy M, Azoulay C, Clappier E, Sébert M, Amable L, et al. Genomic landscape of MDS/CMML associated with systemic inflammatory and autoimmune disease. Leukemia. 2021. https://doi.org/10.1038/s41375-021-01152-1.

3. Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W, et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. NEJM. 2020;383:2628–38.

4. Bourbon E, Heiblig M, Gerfaud-Valentin M, Barba T, Durel CA, Lega J-C, et al. Therapeutic options in Vexas syndrome: insights from a retrospective series. Blood. 2021;137:3682–4.

5. Gurnari C, Pagliuca S, Durkin L, Terkawi L, Awada H, Kongkiatkamon S, et al. Vacuolization of hematopoietic precursors: an enigma with multiple etiologies. Blood. 2021;137:3685–9.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone marrow vexations;Blood;2024-09-12

2. Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes;Blood;2024-09-12

3. Downregulation of UBA1 expression in myelodysplastic neoplasm;Leukemia;2024-08-23

4. Cutaneous Langerhans cell histiocytosis and other systemic inflammatory or autoimmune disease manifestations in the setting of clonal hematopoiesis;eJHaem;2024-07-04

5. Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic review;Frontiers in Oncology;2024-04-11